BOEHRINGER INGELHEIM EXTENDS RESEARCH COLLABORATION WITH ABLYNX FOR ALZHEIMER'S DISEASE

Published on Thursday 21 August 2008 - 07:30

Summary :
GHENT, BELGIUM--(Marketwire - August 21, 2008) - GHENT, Belgium, 21 August 2008 - Ablynx [Euronext Brussels: ABLX], a pioneer in the discovery and development of Nanobodies®, a novel class of...
Read more

Information source

Marketwire - Breaking News Releases

http://www.marketwire.com

Website description
Marketwire - Breaking News Releases

Articles published on this website : 0 / 7 days - 0 / 30 days

Special Caring Today Report on Men as Caregivers Alzheimer's Drug Discovery Foundation Partners With Extreme Athlete The Latest Trends and Research for Drug Discovery Pharmacokinetics Study Confirms Therapeutic-Enabling Quantities of Allon's Drugs RemeGenix Funded by the Alzheimer's Drug Discovery Foundation

Other articles published on other websites on the same day

Authorities Search For Missing Man With Alzheimer's http://www.newsnet5.com/ Kim Stagliano: Why is Ohio Retarded but Connecticut Isn't? http://www.huffingtonpost.com/ Boehringer Extends Collaboration With Ablynx for Alzheimer’s Disease http://www.fdanews.com/ Alzheimer’s research seeks volunteers http://www.onalaskalife.com/ Blueberries Are Little Miracles http://www.stopagingnow.com/ Oshawa caregiver stole $34,000 from war vet: police http://network.nationalpost.com/ The Alzheimer Spouse Website Teams up with Caregiver Cruises and Author Teena Cahill http://www.webwire.com/ How A Vice-Presidential Bid Is A Political Dead End [Politics] http://gawker.com/ Nasdaq warns Oncothyreon; ATS buys majority share of Ganymed; http://www.fiercebiotech.com/ Alzheimer testing in Texas http://www.kvue.com/